Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

Share Price is delayed by 15 minutes
Get Live Data
2.44    -0.005 (-0.20%)
Bid:
2.43
Ask:
2.445
Spread: 0.015 (0.617%)
Market Cap: $8.05b
CBKD Live PriceLast checked at - London Stock Exchange

Intraday Com.int.bk.regs Share Chart

  • This share is an international stock.

Separate- Q12025

13 May 2025 07:00

RNS Number : 4195I
Commercial Intnl Bank (Egypt) SAE
13 May 2025
 

Click on, or paste the following link into your web browser, to view the associated PDF document.

http://www.rns-pdf.londonstockexchange.com/rns/4195I_1-2025-5-13.pdf

Commercial International Bank (Egypt) S.A.E.

Separate Financial Statements

March 31, 2025

 

 

 

 

0

Notes

Mar. 31, 2025

 

Dec. 31, 2024

 

 

Assets

 

 

 

Cash and balances at the central bank

9

67,709,656

 

136,165,920

Due from banks

10

314,144,761

 

270,089,441

Loans and advances to banks, net

12

16,109,873

 

9,555,410

Loans and advances to customers, net

13

361,830,507

 

340,955,698

Derivative financial instruments

930,893

 

819,711

Financial investments

 

 

 

- Financial Assets at Fair Value through OCI

14

259,396,282

 

233,029,903

- Financial Assets at Amortized cost

14

188,018,472

 

167,276,956

Investments in subsidiaries and associates

15

853,165

 

871,525

Non-current assets held for sale

28

159,828

 

159,828

Other assets

16

40,366,933

 

44,175,232

Deferred tax assets

2,536,325

 

2,337,304

Property and equipment

17

4,597,989

3,881,620

Total assets

 

1,256,654,684

 

1,209,318,548

Liabilities and equity

 

 

 

Liabilities

 

 

 

Due to banks

18

4,051,736

 

2,317,715

Due to customers

19

996,119,565

 

967,895,387

Derivative financial instruments

78,314

 

100,571

Current income tax liabilities

5,565,862

 

18,327,968

Other liabilities

20

45,946,585

 

21,347,499

Issued debt instruments

21

5,044,951

 

5,067,781

Other loans

23,948,624

 

23,962,389

Other provisions

22

19,032,774

18,613,060

Total liabilities

 

1,099,788,411

1,057,632,370

Equity

 

 

 

Issued and paid capital

30,431,580

 

30,431,580

Reserves

87,850,844

 

63,125,912

Reserve for employee stock ownership plan (ESOP)

2,184,420

 

1,868,235

Retained earnings*

 

36,399,429

56,260,451

Total equity and net profit for the period / year

 

156,866,273

151,686,178

Total liabilities and equity

 

1,256,654,684

1,209,318,548

 

 

##

The accompanying notes are an integral part of these financial statements.

 

(Review report attached)

 

*Including net profit for the period

 

Islam Zekry

Hisham Ezz Al-Arab

Group CFO & Executive Board Member

CEO & Executive Board Member

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim Income Statement for the period ended March 31, 2025

 

Last 9 Months

 

Last 9 Months

Notes

Mar. 31, 2025

 

Mar. 31, 2024

 

 

 

 

 

Interest and similar income

52,299,641

 

36,544,341

Interest and similar expense

 

(27,003,143)

(17,784,185)

Net interest income

 

25,296,498

18,760,156

 

 

 

Fee and commission income

3,510,324

 

2,684,283

Fee and commission expense

 

(1,586,144)

(1,118,950)

Net fee and commission income

 

1,924,180

1,565,333

 

 

 

Dividend income

12,751

 

610

Net trading income

6

641,395

 

16,202,679

Profits (Losses) on financial investments 

14.1

376,684

 

224,271

Administrative expenses

(3,748,977)

 

(2,840,462)

Other operating income (expenses)

7

(1,735,421)

 

(14,923,188)

Impairment release (charges) for credit losses

 

(68,528)

(1,482,187)

Profit before income tax

 

22,698,582

17,507,212

 

 

 

Income tax expense

26

(6,514,216)

 

(5,722,492)

Deferred tax assets (Liabilities)

26

411,246

161,877

Net profit for the period

 

16,595,612

 

11,946,597

 

 

 

Earnings per share

8

 

 

Basic

4.83

 

3.47

Diluted

4.79

 

3.45

 

 

0

 

Islam Zekry

Hisham Ezz Al-Arab

Group CFO & Executive Board Member

CEO & Executive Board Member

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim Statement of Comprehensive Income for the period ended March 31, 2025

 

 

 

 

Last 9 Months

Last 9 Months

Mar. 31, 2025

 

Mar. 31, 2024

 

 

 

 

Net profit for the period

16,595,612

11,946,597

 

 

 

 

 

Net change on financial assets at fair value through comprehensive income after tax

2,141,325

 

1,977,715

 

Effect of ECL on fair value of debt instruments measured at fair value through comprehensive income

841,407

745,406

 

Total comprehensive income for the period

19,578,344

 

14,669,718

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim Cash Flows for the period ended March 31, 2025

 

 

 

 

 

 

 

 

 

 

 

Notes

Mar. 31, 2025

Mar. 31, 2024

 

 

Cash flow from operating activities

 

 

Profit before income tax

 

22,698,582

17,507,212

Adjustments to reconcile profits to net cash provided by operating activities

 

 

Fixed assets depreciation

17

353,476

261,427

Impairment release/charge for credit losses (Loans and advances to customers and banks)

(1,099,420)

1,772,387

Other provisions release/charge

22

317,074

40,759

Impairment release/charge for credit losses (due from banks)

144,661

(53)

Impairment release/charge for credit losses (financial investments)

1,023,287

(290,147)

Impairment release/charge for other assets

-

(4,782)

Exchange revaluation differences for financial assets at fair value through OCI and AC

212,785

(17,328,576)

Revaluation differences impairment charge for Financial Assets at Fair value through OCI

(13,337)

1,130,412

Revaluation differences impairment charge for Financial Assets at Amortized cost

1,240

95,225

Revaluation differences impairment charge for due from banks

-

101

Net utilized / recovered of other provisions

22

(520)

(4,517)

Exchange revaluation differences of other provisions

22

103,160

3,574,794

Profits/losses from selling property and equipment

(6,006)

-

Profits/losses from selling financial investments at fair value through OCI

14.1

(195,124)

(224,271)

Profits/losses from selling investments in associates

14.1

(181,560)

-

Share based payments

 

316,185

300,000

Operating profits before changes in operating assets and liabilities

 

23,674,483

6,829,971

 

 

Net decrease / increase in assets and liabilities

 

 

Due from banks

121,695,741

42,289,034

Financial assets at fair value through P&L

-

(974,297)

Derivative financial instruments

(142,036)

154,638

Loans and advances to banks and customers

(26,329,852)

(36,747,889)

Other assets

6,045,337

(5,850,432)

Due to banks

18

1,734,021

(6,855,319)

Due to customers

19

28,224,178

117,099,122

Current income tax obligations paid

(948,354)

(276,723)

Other liabilities

 

5,716,835

1,851,912

Net cash generated from (used in) operating activities

 

159,670,353

117,520,017

 

 

Cash flow from investing activities

 

 

Proceeds from sale of investments in associates

226,698

4,782

Payments for investment in subsidiaries

(140,000)

-

Payments for purchases of property, equipment and branches construction

(3,193,660)

(366,618)

Proceeds from selling property and equipment

6,006

-

Proceeds from redemption of financial assets at amortized cost

2,537,401

285,507

Payments for purchases of financial assets at amortized cost

(23,457,385)

(53,240,480)

Payments for purchases of financial assets at fair value through OCI

(29,004,342)

(26,284,875)

Proceeds from selling financial assets at fair value through OCI

6,057,967

26,380,625

Net cash generated from (used in) investing activities

 

(46,967,315)

(53,221,059)

 

Mar. 31, 2025

Mar. 31, 2024

 

 

Cash flow from financing activities

 

 

Other loans

(13,765)

6,700,881

Dividends paid

(14,160,152)

(5,078,792)

Issued debt instruments

(22,830)

1,626,167

Net cash generated from (used in) financing activities

(14,196,747)

3,248,256

 

 

Net (decrease) increase in cash and cash equivalent during the period

98,506,291

67,547,214

Beginning balance of cash and cash equivalent

227,028,744

233,912,193

Cash and cash equivalent at the end of the period

 

325,535,035

301,459,407

 

 

Cash and cash equivalent comprise:

 

 

Cash and balances at the central bank

9

67,709,656

36,542,863

Due from banks

314,289,639

291,980,200

Treasury bills and other governmental notes

11

115,964,828

119,754,167

Obligatory reserve balance with CBE

(43,718,398)

(19,383,018)

Due from banks with maturity more than three months

(14,867,792)

(7,554,480)

Treasury bills and other governmental notes with maturity more than three months

 

(113,842,898)

(119,880,325)

Total cash and cash equivalent

 

325,535,035

301,459,407

 

 

 

 

 

 

 

 

Condensed Separate Interim statement of changes in shareholders' equity

 

Issued and paid capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

Mar. 31, 2024

 

Beginning Balance at 1 January 2024

30,195,010

4,770,354

39,840,707

1,549,445

21,155

(16,808,265)

15,230

29,230,360

1,486,010

90,300,006

Transferred to reserves

-

1,438,320

21,958,960

-

1,663

-

-

(23,398,943)

-

-

Dividend paid

-

-

-

-

-

-

-

(5,366,429)

-

(5,366,429)

Net profit for the period

-

-

-

-

-

-

-

11,946,597

-

11,946,597

Net change on financial assets at fair value through OCI after tax

-

-

-

-

-

1,977,715

-

-

-

1,977,715

Transferred (from) to banking risk reserve

-

-

-

-

-

-

2,694

(2,694)

-

-

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

745,406

-

-

-

745,406

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

300,000

300,000

 Balance at 31 March 2024

30,195,010

6,208,674

61,799,667

1,549,445

22,818

(14,085,144)

17,924

12,408,891

1,786,010

99,903,295

 

 

Issued and paid capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

Mar. 31, 2025

 

 

 

 

 

 

 

 

 

 

Beginning Balance at 1 January 2025

30,431,580

6,208,674

62,422,792

1,549,445

22,818

(7,095,741)

17,924

56,260,451

1,868,235

151,686,178

Transferred to reserves

-

2,771,284

18,971,298

-

2,246

-

-

(21,744,828)

-

-

Dividends paid

-

-

-

-

-

-

-

(14,714,434)

-

(14,714,434)

Net profit for the period

-

-

-

-

-

-

-

16,595,612

-

16,595,612

Net change on financial assets at fair value through OCI after tax

-

-

-

-

-

2,141,325

-

-

-

2,141,325

Transferred (from) to banking risk reserve

-

-

-

-

-

-

(2,628)

2,628

-

-

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

841,407

-

-

-

841,407

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

316,185

316,185

 Balance at 31 March 2025

30,431,580

8,979,958

81,394,090

1,549,445

25,064

(4,113,009)

15,296

36,399,429

2,184,420

156,866,273

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRFEXLBFEELBBBQ
Date   Source Headline
12th May 202610:18 amRNS1st Quarter Results
12th May 202610:16 amRNSCIB Consolidated Financial Statements 1Q26
12th May 202610:15 amRNS1Q26 Earnings Release
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
24th Feb 202612:31 pmRNSItems of Extraordinary GA
24th Feb 20267:00 amRNSPress Release dated 23th February 2026
19th Feb 20261:20 pmRNSItems of Extraordinary GA
19th Feb 20261:17 pmRNSInvitation to the Extraordinary GA 2026
19th Feb 20268:00 amRNSItems of OGA 2026
19th Feb 20268:00 amRNSInvitation to the OGA March 15
10th Feb 20267:00 amRNSCIB Summary of Board Resolution 9 Feb 2026
10th Feb 20267:00 amRNSFY25 Earnings Release
10th Feb 20267:00 amRNSCIB IFRS Consolidated Financial Statements FY25
15th Dec 20257:00 amRNSChange in Board of Directors
3rd Dec 20254:35 pmRNSCIB Bonus Shares Distribution 2025
4th Nov 20257:00 amRNSCIB Condensed Consolidated 3rd Quarter Results
4th Nov 20257:00 amRNSCIB 9M25 Earnings Release
4th Nov 20257:00 amRNS3rd Quarter Results
25th Sep 20253:55 pmRNSSummary of Resolutions - GAM September 2025
1st Sep 20257:02 amRNSInvitation to General Assembly September 2025
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Consolidated Financials
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Separate Financials
22nd Jul 20257:00 amRNS2Q25 Earnings Release
28th May 20256:00 pmRNSChanges to the Board of Directors
13th May 20257:00 amRNSSeparate- Q12025
13th May 20257:00 amRNS1Q25 Press Release
13th May 20257:00 amRNSConsolidated Financial Position at March 31.2025
24th Mar 20257:00 amRNSOrdinary General Assembly Resolutions Summary 2025
28th Feb 20257:00 amRNSGeneral Assembly 2025 - Discussion Items - amended
27th Feb 20257:47 amRNSInvitation to General Assembly 2025
27th Feb 20257:15 amRNSGeneral Assembly 2025 - Discussion Items
19th Feb 20257:00 amRNSCIB Annual Financial Report
19th Feb 20257:00 amRNSCIB FY2024 Earnings Release
6th Nov 20247:58 amRNSCIB gets regulatory approvals to changes to BoD
4th Nov 20247:00 amRNSEarnings Release 3Q.2024
4th Nov 20247:00 amRNSCIB-Separate Financial Statements 3Q.2024
4th Nov 20247:00 amRNSCIB-Consolidated Financial Statements 3Q.2024
1st Oct 20242:00 pmRNSCIB obtaining Long term loan from IFC
16th Sep 20248:00 amRNSChanges in CIB's Board of Directors
22nd Jul 20247:00 amRNSCIB H1-2024 Separate Financial Statements - E
22nd Jul 20247:00 amRNSH1.2024 Press Release
22nd Jul 20247:00 amRNSCIB H1-2024 Consolidated Financial Statements
13th May 20247:00 amRNS1st Quarter Results - Separate Statements
13th May 20247:00 amRNS1st Quarter Results - Consolidated Statements
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.